gbr 12935 has been researched along with levodopa in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, SH; Bostwick, JR; Le, WD | 1 |
| Jellinger, K; Pearce, RK; Seeman, P; Tourtellotte, WW | 1 |
| Gordon, I; Rehavi, M; Weizman, R | 1 |
| Gomita, Y; Matsunaga, K; Oishi, R; Sato, T; Shuto, H; Suemaru, K; Tsuruta, Y | 1 |
4 other study(ies) available for gbr 12935 and levodopa
| Article | Year |
|---|---|
Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum.
Topics: Aging; Animals; Biological Transport; Corpus Striatum; Dopamine; Embryonic and Fetal Development; Gestational Age; Levodopa; Male; Nerve Endings; Piperazines; Rats; Rats, Inbred Strains; Tritium | 1992 |
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Binding Sites; Dopamine; Female; Humans; Levodopa; Ligands; Male; Middle Aged; Parkinson Disease; Piperazines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia | 1990 |
Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
Topics: Amantadine; Animals; Benztropine; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperazines; Rats; Reserpine | 1996 |
Inhibition of neuronal dopamine uptake by some antiallergic drugs.
Topics: Animals; Anti-Allergic Agents; Behavior, Animal; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Synergism; Histamine H1 Antagonists; Levodopa; Male; Mice; Monoamine Oxidase Inhibitors; Neurons; Pargyline; Piperazines; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Synaptosomes | 1998 |